000 01210 a2200337 4500
005 20250512023529.0
264 0 _c19870713
008 198707s 0 0 eng d
022 _a0002-9343
024 7 _a10.1016/0002-9343(87)90433-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuck, M
245 0 0 _aRebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
_h[electronic resource]
260 _bThe American journal of medicine
_cMay 1987
300 _a92-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aGastrins
_xblood
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOctreotide
650 0 4 _aPancreatic Neoplasms
_xdrug therapy
650 0 4 _aRadionuclide Imaging
650 0 4 _aSomatostatin
_xadministration & dosage
650 0 4 _aZollinger-Ellison Syndrome
_xdrug therapy
700 1 _aKvols, L K
700 1 _aO'Dorisio, T M
773 0 _tThe American journal of medicine
_gvol. 82
_gno. 5B
_gp. 92-5
856 4 0 _uhttps://doi.org/10.1016/0002-9343(87)90433-5
_zAvailable from publisher's website
999 _c2890729
_d2890729